Cellinta Companies

Cellinta Limited is a biotechnology company focused on developing cancer-identifying technology using gene therapy. Their main goal is to create a platform for locating regulatory circuits specific to cancer stem cells. This technology can be used in gene therapies to selectively deliver anti-cancer payloads and disrupt multiple pathways required for tumor growth and immune stimulation simultaneously. Cellinta's achievements include advancements in the field of targeted cancer treatment and the potential to revolutionize cancer therapy through their innovative approach.
Technology:
Gene Therapies (disease treatment)
Founded Date:
2019
Industry:
Advanced BioTech R&D
Headquarters:
London, England, United Kingdom